We are live on ! Find out more
Parnassus Investments

Parnassus Investments Portfolio holdings

AUM $37.4B
1-Year Est. Return 35.42%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$13.2B
AUM Growth
+$1.55B
Cap. Flow
+$794M
Cap. Flow %
6%
Top 10 Hldgs %
33.19%
Holding
118
New
8
Increased
43
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$390M
2
AGN
Allergan plc
AGN
+$212M
3
NOV icon
NOV
NOV
+$144M
4
PRGO icon
Perrigo
PRGO
+$135M
5
PNR icon
Pentair
PNR
+$81.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.75%
2 Industrials 17.29%
3 Technology 16.8%
4 Consumer Staples 12.12%
5 Energy 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.16T
$541M 4.09%
20,572,226
+14,525,610
+240% +$390M
AMAT icon
2
Applied Materials
AMAT
$376B
$519M 3.92%
20,835,005
-362,527
-2% -$8.19M
MSI icon
3
Motorola Solutions
MSI
$80.2B
$458M 3.46%
6,826,360
+15,951
+0.2% +$1.02M
PNR icon
4
Pentair
PNR
$9.77B
$457M 3.45%
10,254,709
+1,850,068
+22% +$81.2M
AGN
5
DELISTED
Allergan Inc
AGN
$452M 3.41%
2,124,700
-879,265
-29% -$175M
QCOM icon
6
Qualcomm
QCOM
$174B
$441M 3.33%
5,927,400
+685,191
+13% +$50.1M
IRM icon
7
Iron Mountain
IRM
$36B
$408M 3.08%
10,556,778
+1,279,528
+14% +$46.5M
PG icon
8
Procter & Gamble
PG
$334B
$398M 3.01%
4,368,745
+7,400
+0.2% +$651K
GILD icon
9
Gilead Sciences
GILD
$182B
$364M 2.75%
3,857,820
+494,529
+15% +$51.1M
NOV icon
10
NOV
NOV
$7.31B
$356M 2.69%
5,436,870
+2,061,820
+61% +$144M
EBAY icon
11
eBay
EBAY
$46.1B
$354M 2.67%
14,969,038
+1,880,421
+14% +$42.7M
CVS icon
12
CVS Health
CVS
$120B
$341M 2.57%
3,538,280
-81
-0% -$7.14K
PRGO icon
13
Perrigo
PRGO
$2B
$336M 2.54%
2,009,300
+866,321
+76% +$135M
MDLZ icon
14
Mondelez International
MDLZ
$79.4B
$334M 2.52%
9,197,270
-5,398
-0.1% -$196K
XYL icon
15
Xylem
XYL
$26B
$299M 2.26%
7,843,373
+59,602
+0.8% +$2.18M
TRI icon
16
Thomson Reuters
TRI
$45.9B
$287M 2.16%
6,122,178
-46,943
-0.8% -$2.08M
EXPD icon
17
Expeditors International
EXPD
$24.7B
$284M 2.15%
6,370,867
+344,085
+6% +$14.8M
PEP icon
18
PepsiCo
PEP
$192B
$281M 2.12%
2,969,250
-1,365
-0% -$131K
AAPL icon
19
Apple
AAPL
$4.62T
$278M 2.1%
10,068,832
-6,097,176
-38% -$166M
SYY icon
20
Sysco
SYY
$39.4B
$277M 2.09%
6,978,850
+43,535
+0.6% +$1.69M
PX
21
DELISTED
Praxair Inc
PX
$274M 2.07%
2,114,540
+137,453
+7% +$17.4M
SCHW
22
Charles Schwab
SCHW
$188B
$272M 2.06%
9,016,400
+764,831
+9% +$21.7M
SJR
23
DELISTED
Shaw Communications Inc.
SJR
$268M 2.02%
9,913,404
-1,595
-0% -$41.4K
UPS icon
24
United Parcel Service
UPS
$89.8B
$267M 2.01%
2,399,390
-656
-0% -$69.2K
NVS icon
25
Novartis
NVS
$291B
$254M 1.92%
3,054,079
-65
-0% -$5.39K

Similar funds

Parnassus Investments's Q4 2014 Portfolio in Review

As of Q4 2014, Parnassus Investments held 118 positions worth $13.2B, up 13% from $11.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Parnassus Investments deployed $794M of net new capital in Q4 2014, opening 8 new positions and adding to 43 existing holdings. Its largest new stake was Allergan plc: 847,000 shares worth $218M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Allergan Inc, an estimated $175M trimmed.

  • Parnassus Investments's largest Q4 2014 buy was Allergan plc: 847,000 shares worth $218M.
  • Parnassus Investments added most to Alphabet (Google) Class C in Q4 2014, an estimated $390M increase.
  • Parnassus Investments's biggest Q4 2014 reduction was Allergan Inc, cutting an estimated $175M.
  • Parnassus Investments fully exited ENERGY XXI LTD COM SHS in Q4 2014, selling an estimated $29.5M.
  • Parnassus Investments's ten largest holdings make up 33% of its $13.2B portfolio in Q4 2014.
  • Parnassus Investments opened 8 new positions and closed 9 in Q4 2014.
  • Parnassus Investments's portfolio value rose 13% quarter-over-quarter to $13.2B.

Based on Parnassus Investments's 13F filing for Q4 2014, filed 10 Feb 2015.